PT Merck Tbk (IDX:MERK)
Indonesia
· Delayed Price · Currency is IDR 4,300.00
+170.00 (4.12%)
Apr 29, 2026, 4:09 PM WIB
PT Merck Tbk Revenue
In the year 2025, PT Merck Tbk had annual revenue of 1.20T IDR with 15.81% growth. PT Merck Tbk had revenue of 386.56B in the quarter ending December 31, 2025, with 36.59% growth.
Revenue
1,200.67B
Revenue Growth
+15.81%
P/S Ratio
1.54
Revenue / Employee
3.30B
Employees
364
Market Cap
1,850.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,200.67B | 163.92B | 15.81% |
| Dec 31, 2024 | 1,036.75B | 75.31B | 7.83% |
| Dec 31, 2023 | 961.43B | -163.17B | -14.51% |
| Dec 31, 2022 | 1,124.60B | 60.20B | 5.66% |
| Dec 31, 2021 | 1,064.39B | 408.55B | 62.29% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 2,589.44B |
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5,368.32B |
| PT Kimia Farma Tbk | 9,223.33B |
| PT Prodia Widyahusada Tbk | 2,281.70B |
| PT Murni Sadar Tbk | 1,357.85B |
| PT Darya-Varia Laboratoria Tbk | 2,123.13B |